Senate Resolution 5-01953-25, introduced by Senator Davis, designates May as National Hypertension Month in Florida. The resolution aims to raise awareness about hypertension, a condition affecting nearly half of all adults in the U.S. and a significant risk factor for cardiovascular diseases. It highlights the alarming statistics surrounding hypertension, including its contribution to approximately 700,000 deaths annually and the fact that only about 25% of affected adults have their condition under control. The resolution also addresses the substantial healthcare costs associated with hypertension, which amount to around $131 billion per year.

Furthermore, the resolution emphasizes the importance of public education and advocacy for improved access to innovative treatment therapies, such as recently approved renal denervation therapies for resistant hypertension. These advancements offer hope for patients who do not respond to traditional treatments. By designating May as National Hypertension Month, the Senate seeks to promote efforts to prevent, detect, and manage hypertension effectively, ultimately aiming to improve public health outcomes in Florida.